Digest Network Come funziona
Network
/
Società
Sa
Non verificato

Sandoz Group

Di cosa scriviamo

Annunci EconomiciFarmaceuticaManagement/Organizzazione AziendalePolitica InternazionalePubblicità/Marketing/Media/Comunicazione

21 comunicati stampa

Guarda tutti i comunicati
11/08/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
06/08/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
29/07/2025
Farmaceutica
Pubblicità/Marketing/Media/Comunicazione
Annunci Economici
Politica Internazionale
Sandoz signs non-binding term sheet with Evotec SE to acquire its Just-Evotec Biologics in-house development and manufacturing capabilities in Toulouse, France
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
01/07/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz further asserts leadership in biosimilars, breaking ground on new Slovenia facility to expand European biosimilar hub and global market reach
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
01/06/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
21/05/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz launches Pyzchiva® autoinjector, first commercially available in Europe for ustekinumab biosimilars
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
29/04/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz reports Q1 2025 net sales in line with company expectations; full-year guidance confirmed
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
29/04/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
15/04/2025
Farmaceutica
Annunci Economici
Politica Internazionale
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0
14/04/2025
Farmaceutica
Annunci Economici
Politica Internazionale
[Corrected] Sandoz files antitrust litigation against Amgen regarding patient access to etanercept biosimilar in the US
Fonte
Sandoz Group
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0